The global atherosclerosis drugs market size reached USD 48.40 Billion in 2021 and is expected to register a revenue CAGR of 2.5% during the forecast period, according to latest analysis by Emergen Research. An increase in the prevalence of atherosclerosis & cardiovascular diseases is the main factor driving the revenue growth of the atherosclerosis drugs market. Globally, the number of cardiovascular disease-related deaths and disabilities has been continuously increasing over the past 30 years. The illness, which includes heart disease and stroke, was to blame for a startling one-third of all fatalities globally in 2019. In the United States alone, heart disease is the leading cause of death for both sexes and members of the majority of racial and ethnic groups. Cardiovascular disease claims one life in the United States every 34 seconds.
The Atherosclerosis Drugs Marketplace Report offers wide-ranging information and facts about the Atherosclerosis Drugs market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends. The report is formulated with the updated and latest information of the global Atherosclerosis Drugs market further validated and verified by the industry experts and professionals. The Global Atherosclerosis Drugs Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Atherosclerosis Drugs market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market.
Get a sample of the report @https://www.emergenresearch.com/request-sample/1300
Some Key Highlights From the Report
Statins segment accounted for the largest revenue share in 2021. Lipid-lowering therapy has been the cornerstone of cardiovascular risk reduction and prevention. Statin drugs have been shown to considerably reduce cardiovascular disease morbidity and mortality as well as blood cholesterol levels. It is yet unknown whether these benefits result exclusively from lowering lipid levels or partly from pleiotropic effects (effects unrelated to cholesterol). Our understanding of how statins affect atherosclerotic plaque has improved owing to the use of multi-detector coronary computed tomography angiography and intravascular ultrasound in cardiac imaging. Notably, statins help plaque to shrink when its lipid content decreases. By thickening the fibrous caps and promoting macro calcification of atherosclerotic plaque, these drugs aid in the stability of atheroma.
Cholesterol lowering medication segment accounted for the largest revenue share in 2021. The growing use of these medications is anticipated to drive the segment’s market revenue growth. The development of fatty deposits in the arteries can be slowed down, stopped, or even reversed by aggressively reducing Low-Density Lipoprotein (LDL), also referred to as the “bad” cholesterol. Statins are frequently employed to lower cholesterol, keep arteries in good condition, and prevent atherosclerosis. There are other additional drugs that decrease cholesterol. Some of them include niacin, fibrates, and bile acid sequestrants. These are the main factors influencing the segment’s expansion.
The online pharmacy segment accounted for the largest revenue share in 2021. This market segment is growing owing to an increase in the number of online services available as well as a sharp rise in internet users. Customers use e-commerce websites to avoid the trouble of going shopping in person, where they can choose from a wide variety of items and take advantage of beneficial bargains and discounts. E-commerce is changing how individuals acquire and sell medications for atherosclerosis. E-commerce websites offer a variety of advantages over conventional sales channels when it comes to product availability, cost, shipping alternatives, and many other important factors. The majority of clients also prefer online shopping due to the lower prices it gives compared to other retailers and brick-and-mortar businesses.
Leading Companies of the Atherosclerosis Drugs Industry and Profiled in the Report are:
Sanofi, Hoffmann La-Roche Ltd, Bayer AG, Merck & Co., Inc., Pfizer Inc., Novartis AG, GSK plc, Janssen Global Services, LLC, Amgen Inc., Mylan N.V.
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/atherosclerosis-drugs-market
Analysis of the segments and their growth projection is carried out by extensive historical and current analysis of the market scenario. Further, the report offers details about the factors and features of the Atherosclerosis Drugs market expected to boost the growth of the industry in the coming years.
Emergen Research has segmented global atherosclerosis drugs market on the basis of drug class, medication, distribution channel, and region:
Drug Class Outlook (Revenue, USD Billion; 2019-2030)
Statins
Fibrates
Vitamins
Others
Medication Outlook (Revenue, USD Billion; 2019-2030)
Cholesterol Lowering Medication
Beta Blockers
Calcium Channel Blockers
Diuretics
Others
Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional Analysis:
The report sheds light on the region expected to dominate the Atherosclerosis Drugs market in the coming years. The report estimates the market size in terms of volume and value and offers an accurate estimate of the market share each region is anticipated to hold during the forecast period. The report analyzes the spread of the Atherosclerosis Drugs market in key geographies covering North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The regional analysis offers an idea about the production and consumption pattern, import/export, supply and demand ratio, revenue contribution, market share and size, and the presence of prominent players in each region.
Request customization of the report @https://www.emergenresearch.com/request-for-customization/1300
The report covers key points of the market, including the standards, regulations, and policy changes applied by the government on the industry for the coming years. The report encompasses thorough research carried out by the application of advanced analytical tools such as SWOT analysis and Porter’s Five Forces analysis to pinpoint the growth trends and patterns. Factors likely to influence the growth of the market, current trends, opportunities, restraining factors, and business landscape are discussed in-depth in the market study.
Key Questions Answered in the Report:
What is the growth rate of the Atherosclerosis Drugs market? What is the anticipated market valuation of Atherosclerosis Drugs industry by 2030?
What are the key growth driving and restraining factors of the Atherosclerosis Drugs market?
Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
What are the key opportunities and growth prospects of the Atherosclerosis Drugs industry over the forecast period?
Which region is expected to show significant growth in the coming years?
Click here to Buy Now @https://www.emergenresearch.com/select-license/1300
Thank you for reading our report. Please connect with us to know more about the report or for requesting the customization of the report. Our team will ensure the report is best suited to your requirements.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/atherosclerosis-drugs-market